Sterile Single Use Peripheral Arteries Percutaneous Transluminal Angioplasty(PTA) Dilatation Catheter
- Risk class
- Class IIa
- CND nomenclatures code
- C010402020101
- Trade name
- Principal® Peripheral Arteries Percutaneous Transluminal Angioplasty(PTA) Dilatation Catheter
- Implantable
- No
- Reusable
- No
- Measuring function
- No
- Primary DI
- 06935456205881
- Basic UDI
- 69354562PLYL06XM
- Active status
- No
- Manufacturer name
- Princeton Medical Scientific Co.,Ltd
- Country
- China
- Country type
- NON_EU
- Address
- No.8 Fukang West Street, Yushu Industrial Park, Guangzhou city, Guangdong Province
- pssu@pulinmed.com
- Name
- Wellkang Ltd
- SRN
- XI-AR-000001836
- Country
- United Kingdom (Northern Ireland only)
- Address
- Enterprise Hub, NW Business Complex, Derry
- AuthRep@CE-marking.eu
- Telephone
- +44(33)33031126
- Competent authority
- The Medicines and Healthcare Products Regulatory Agency
- Applicable legislation
- MDR (REGULATION (EU) 2017/745 on medical devices)
- Placed on the market
- Türkiye
- Market available
- Türkiye:None~None
- Human tissues
- No
- Animal tissues
- No
PTA BALLOON DILATATION CATHETERS
Access comprehensive regulatory information for Sterile Single Use Peripheral Arteries Percutaneous Transluminal Angioplasty(PTA) Dilatation Catheter in the European Union medical device market through Pure Global AI's free database. This Class IIa device is registered with EU EUDAMED under Primary DI 06935456205881 and manufactured by Princeton Medical Scientific Co.,Ltd in China.
This page provides complete registration details including trade name (Principal® Peripheral Arteries Percutaneous Transluminal Angioplasty(PTA) Dilatation Catheter ), manufacturer information, authorized representative details, competent authority (The Medicines and Healthcare Products Regulatory Agency), and regulatory compliance data from the official EU EUDAMED medical device database. Pure Global AI offers free access to the European Union's complete medical device registry, helping global MedTech companies navigate EU MDR regulations efficiently.